Disease Predilection and Molecular Heterogeneity of the Murine Aorta are Intrinsic to the Vessel Wall by Lo, Sheng-fu
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
11-3-2009
Disease Predilection and Molecular Heterogeneity
of the Murine Aorta are Intrinsic to the Vessel Wall
Sheng-fu Lo
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Lo, Sheng-fu, "Disease Predilection and Molecular Heterogeneity of the Murine Aorta are Intrinsic to the Vessel Wall" (2009). Yale









DISEASE PREDILECTION AND MOLECULAR HETEROGENEITY OF THE 
MURINE AORTA ARE INTRINSIC TO THE VESSEL WALL 
 
 
A Thesis Submitted to the 
Yale University School of Medicine 
in Partial Fulfillment of the Requirements for the 









 Vascular diseases such as atherosclerosis or aneurysmal disease preferentially 
affect different parts of the arterial system.  Despite this heterogeneous pattern of disease 
within the arterial system, the contribution of different smooth muscle cell phenotypes to 
this pattern has not been well studied.  We investigated aortic disease susceptibility and 
epigenetic differences within different regions of the murine aorta.  Quantitative analyses 
showed more numerous atherosclerotic plaques and larger aneurysms in the ascending 
aorta compared to the descending thoracic aorta in apoE–/– and fbn1C1039G/+ mice, 
respectively.  Interferon-γ and transforming growth factor-β responses, characteristic of 
these disease processes, were greater in the ascending vs. descending thoracic aorta.  
There was differential gene expression within the aorta and a “Hox code” was found for 
the murine arterial vasculature along the anterior–posterior axis.  Transplantation of 
ascending and descending thoracic aortic segments to the abdominal aorta of syngeneic 
recipients confirmed that the propensity for atherosclerotic disease and the expression of 
selective molecular markers were innate properties of the vessel wall and not dependent 
on regional hemodynamic factors or paracrine signals from surrounding tissues.  The 
epigenetic changes were also stable in cultured cells despite identical in vitro conditions.  
Our work supports the concept of intrinsic differences between vascular smooth muscle 
cells from various arteries that may play a role in disease pathogenesis. 
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 Vascular diseases such as atherosclerosis or aneurysms selectively affect different 
parts of the arterial system.  In humans, atherosclerosis involves the abdominal aorta 
much more than the thoracic aorta, and lesions tend to be much more prominent around 
the ostia of major branches (1-6).  Within the thoracic portion of the aorta, the descending 
aorta has more atherosclerosis than the ascending aorta.  In descending order after the 
lower abdominal aorta, the most extensively involved vessels are the coronary arteries, 
popliteal arteries, internal carotid arteries, and vessels of the circle of Willis (7).  
Similarly, aneurysmal disease in humans also show striking propensity for specific parts 
of the arterial vasculature, including the infrarenal abdominal aorta for atherosclerotic 
aneurysms and arterial bifurcations in the circle of Willis for saccular aneurysms (7).  
Aneurysms with a genetic inheritance show a striking predilection for different parts of 
the thoracic aorta.  Aneurysms associated with the FBN1 mutation of Marfan syndrome 
develop in the aortic root (8).  In contrast, other monogenic aneurysmal diseases spare the 
aortic root and affect the ascending aorta preferentially, such as mutations in MYH11 or 
ACTA2 (9, 10). 
 The topographical distribution of atherosclerotic and aneurysmal disease within 
the arterial vasculature has been well-described in the literature.  There is overwhelming 
consensus in the literature that points to hemodynamic factors in explaining this 
phenomenon.  For atherosclerosis and atherosclerotic aneurysms, studies have shown that 
they occur at sites with slow or disturbed blood flow and low wall sheer stresses (11-13).  
An initial injury that might result from excessive wall sheer stress on endothelial cells 




intracranial aneurysm development and growth in computational models (14, 15).  Cyclic 
stresses along with increased flow wave velocity compared to control subjects are 
potential hemodynamic factors in the pathogenesis of aortic root aneurysms in Marfan 
syndrome (16, 17).  Compared to the amount of research that has looked at the 
mechanical factors contributing to this heterogeneous pattern of disease within the 
arterial system, there is a dearth of research that has looked at the contribution of 
different smooth muscle cell phenotypes to this pattern.  In order to better understand the 
contributions of factors that are intrinsic to vascular smooth muscle cells (VSMCs) in this 
topographical disease development, we focused on epigenetic differences present within 
the arterial vasculature, specifically with regards to Hox genes. 
 Hox genes are homeodomain-containing transcription factors that were first 
described in Drosophila for their ability to cause segmental homeotic transformations of 
the body plan, that is, the formation of body parts in inappropriate contexts or locations 
(18).  For example, ectopic expression of the antennapedia gene in Drosophila results in 
the formation of a complete set of middle legs in place of antennae (19).  Hox genes 
belong to a superfamily of homeobox genes that is defined by a conserved 61-amino acid 
DNA-binding motif known as the homeodomain (20).  As “master regulators” of 
development, the homeobox gene superfamily controls many cellular processes including 
proliferation, differentiation, apoptosis, cell shape, cell adhesion, and migration (21).  
Since its first discovery, homeobox genes have been identified in all eukaryotic species 





 While flies have eight Hox genes located in a single cluster, mammals have 39 
Hox genes arranged in four clusters, labeled A through D (22).  Tandem duplications 
within the ancestral Hox cluster followed by genome duplication events have resulted in 
a relatively fixed arrangement in mammals within the four clusters, composed of 2 to 4 
members of 13 paralogous groups numbered 1 through 13.  In a wide variety of animals, 
ranging from nematodes to mice, mutations in Hox genes result in morphological defects 
that are restricted to discrete segmental zones along the anterior–posterior (AP) axis, and 
sometimes include homeotic transformations similar to those that are seen in Drosophila 
(23, 24).  Therefore, one conserved function of different members of the Hox gene family 
is to select one AP axial identity over another.  The most obvious read-out of AP 
patterning in vertebrates is the axial skeleton, with a cephalad to caudal progression of 
the Hox paralogues 1 through 13 as we progress from the cervical to the sacral spine (22). 
 Although homeoproteins were originally thought to act primarily as “high-level” 
regulators controlling expression of transcription factors and morphogen signals, there is 
mounting evidence that they directly regulate genes that mediate cell proliferation, 
apoptosis, adhesion, and migration (21).  However, despite the fact that homeoproteins 
were first identified in 1983, their transcriptional targets have remained elusive due to the 
fact that they display relatively promiscuous DNA-binding in vitro, making the 
identification of target genes difficult (25).  Furthermore, their functions in postnatal and 
adult tissues are largely subject to speculation (26).  This is true of the adult 
cardiovascular system as well despite Hox genes being a prime candidate for controlling 




 Despite the documented expression of Hox genes in VSMCs and ECs, there is a 
lack of data addressing the differential expression of the Hox paralogues in the arterial 
vasculature (27).  Furthermore, there is a near-void of data concerning the phenotypic 
changes in the cardiovascular system of the numerous Hox gene-targeted and transgenic 
mice that have been described in the literature.  The only exception is the Hoxa3 
homozygous mutant mice, which develop malformations in the carotid artery system (28-
30).  In vitro studies of Hox gene expression in ECs seem to suggest a role in the 
regulation of angiogenesis in both physiological processes and pathological conditions 
(31-33).  Interestingly, HOXB7 has been found to be expressed in the media and 
neointima adjacent to calcifications in human atherosclerotic plaques and further in vitro 
studies seem to suggest a role in expansion of immature cell populations or 
dedifferentiation of mature cells, though in vivo evidence supporting this is lacking (34). 
 A prerequisite for defining the role of Hox genes in normal and pathological 
conditions and its underlying molecular mechanisms is information about Hox expression 
patterns in adult vasculature in vivo.  To this end, we characterized the heterogeneity of 
vascular diseases in mice, which differs than that of humans, and identified cytokine 
responses that may be responsible for these differences.  Furthermore, we defined a “Hox 
code” of the murine vasculature as well as associated molecular differences, specifically 
focusing on the ascending and descending thoracic aorta.  Finally, we utilized a murine 
transplant model to examine the effect of hemodynamic flow on vascular disease 




MATERIALS AND METHODS 
Mice 
 We purchased C57BL/6, apoE–/–, SM22-Cre, and mT/mG mice from The Jackson 
Laboratory (C57BL/6J, B6.129P2-Apoetm1Unc/J, Tg(Tagln-cre)1Her/J, and 
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J respectively).  Fbn1C1039G/+ mice were obtained 
from H.C. Dietz (Johns Hopkins University School of Medicine, Baltimore, MD).  All 
experimental animal protocols were approved by the Yale University Institutional Animal 
Care and Use Committee. 
 
Atherosclerotic lesion analysis 
 The extent and distribution of atherosclerosis was examined in apoE–/– mice using 
a method described by Yang et al (35).  The animals were anesthetized and the aorta was 
perfused using normal saline.  The entire aorta was harvested ex vivo, cut open 
longitudinally, and pinned flat on a silicone-coated dissecting dish.  The aorta was fixed 
with 10% neutral buffered formalin for 24 hours.  After fixation, the aorta was washed 
with phosphate-buffered saline (PBS) for 1 hour and stained with oil red O solution 
(0.3% in isopropyl alcohol and then diluted with water, 3:2, vol/vol) for 50 minutes.  
Excess stain was washed off with 60% isopropyl alcohol.  Images were captured with a 
Carl Zeiss AxioCam MRc digital camera mounted on a Carl Zeiss Axioskop 2 FS plus 
microscope.  The atherosclerotic plaque areas were quantified using ImageJ software 






Histology and morphometry 
 Microscopic morphometric evaluation was performed on Elastica–van Gieson 
(EVG)–stained 5-µm cross sections of aortic root, ascending, and descending thoracic 
aorta of C57BL/6 and fbn1C1039G/+ mice using ImageJ software (National Institutes of 
Health) and standard staining techniques.  The perimeters of the external elastic lamina 
(EEL) were outlined and area measurements were calculated (under the assumption that 
vessel cross sections were circular).  The vessel area (within the EEL) of five cross 
sections were assessed and averaged for each vessel segment. 
 
ApoE–/– arterial transplantation 
Transplantation procedures performed by Lingfeng Qin 
 Ascending and descending thoracic aortic segments, as defined from the 
myocardial junction to the origin of the brachiocephalic artery and a similar length of 
aorta from vertebral bodies T5 to T6, respectively, were harvested from male apoE–/– 
mice at 3 weeks of age.  These were then interposed into the infrarenal abdominal aortae 
of male apoE–/– mice at 10 weeks of age using an end-to-end microsurgical anastomotic 
technique as previously described (36, 37).  Under general anesthesia, midline 
laparotomy was used to obtain proximal and distal control of the mouse abdominal aorta, 
below the renal arteries and above the iliac arterial bifurcation.  Arterial anastomoses 
were performed using 18× magnification and 10-0 monofilament nylon suture.  The end 
of the donor aorta was anastomosed to the end of the mouse aorta distal to the renal 
vessels, and the other end to the mouse aorta just proximal to the iliac bifurcation.  Upon 
completing the distal anastomosis, vascular integrity was restored and hemostasis 




flooded with warmed sterile saline before closure.  Anastomosis times varied between 15 
and 20 minutes.  After wound closure, animals were monitored under heating lights to 
avoid hypothermia.  Animals recovered quickly, and hind limb function was a reliable 
indicator of early graft patency.  Mice with hind limb paralysis were reanesthetized, then 
killed.  The mice were subsequently put on a “Western” diet (adjusted calories diet with 
42% from fat, Harlan Laboratories) and this high-fat diet was maintained for 24 weeks.  
The mice were subsequently sacrificed and the aortae were harvested ex vivo and 
analyzed for atherosclerosis development by oil red O staining as described above. 
 
Organ culture 
 Male C57BL/6 mice were anesthesized at 10 weeks of age and the arterial system 
was perfused with normal saline before the ascending aorta and descending thoracic aorta 
as defined above were excised.  The aortic segments were subsequently cultured on tissue 
culture-grade plastic in M199 media supplemented with 2 mmol/l L-glutamine, 100 
units/ml penicillin, and 100 µg/ml streptomycin (Invitrogen).  The aortic segments were 
treated with either recombinant mouse interferon (IFN)-γ (R&D Systems) at 10 ng/ml, 
recombinant human transforming growth factor (TGF)-β1 (R&D Systems) at 10 ng/ml, 
or vehicle control.  The aortic segments were flash frozen after 6 hours for further RNA 
analyses. 
 
Harvesting of arteries 
 Male C57BL/6 mice were anesthesized at 10 weeks of age and the arterial system 




descending thoracic aorta, abdominal aorta, and the common femoral arteries were 
excised.  The ascending aorta was harvested from its junction with the myocardium to the 
origin of the brachiocephalic artery.  The descending aorta was harvested at the vertebral 
bodies from T5 to T6.  The abdominal aorta was harvested below the origins of the renal 
arteries to the ilial bifurcation.  The aorta immediately proximal and distal to the aortic 
isthmus was also harvested in 2-mm segments while the aortic isthmus, or that portion of 
the aorta from the left subclavian artery to the insertion of the ligamentum arteriosum, 
was discarded.  The segments were flash frozen for further RNA analyses. 
 
C57BL/6 arterial transplantation 
Transplantation procedures performed by Lingfeng Qin 
 Ascending and descending thoracic aortic segment transplants were performed as 
above using 3-week-old male C57BL/6 mice as the donors and 10-week-old male 
C57BL/6 mice as the recipients.  The transplanted arterial grafts were harvested after 24 
weeks.  The animals were anesthetized and arterial grafts were perfused and excised 
before death.  The recipient ascending and descending thoracic aortic segments and the 
abdominal aortae immediately distal to the arterial grafts were also harvested.  The aortic 
segments were flash frozen for further RNA analyses. 
 
Generation of mice with smooth muscle cell-specific expression of EGFP 
 Smooth muscle cell-specific expression of membrane-targeted EGFP (mG) was 
achieved by the breeding of homozygous floxed mT/mG mice with homozygous SM22-
Cre mice, resulting in SM22-mG/mT mice with smooth muscle cell-specific expression 




tissues due to the combination of a strong and ubiquitous CMV β-actin enhancer-
promoter and the ROSA26 targeting locus (38).  The Sm22-mG/mT mice were 
genotyped by PCR and its phenotype was confirmed by fluorescence microscopy.  
Vessels were embedded in Optimal Cutting Temperature medium and 5-µm cross 
sections were stained with 4',6-diamidino-2-phenylindole dihydrochloride (DAPI) 
(Vector Laboratories) to assess for nuclear morphology and mG/mT signal strength. 
 
Isolation of ascending and descending VSMCs from SM22-mG/mT mice 
 SM22-mG/mT mice were anesthetized with ketamine and xylazine and sacrificed 
at 6 weeks of age.  The ascending and descending thoracic aortic segments were 
harvested as mentioned above.  The vessels were rinsed and digested in 1 mg/ml 
collagenase A (Roche Applied Science) in Hank's balanced salt solution (HBSS) for 10 
minutes at 37ºC.  The remaining adventitia was removed under a dissecting microscope 
and the vessels were cut into small pieces and incubated overnight at 37ºC in growth 
medium consisting of Dulbecco's Modified Eagle's Medium supplemented with 10% fetal 
bovine serum, 100 units/ml penicillin, and 100 µg/ml streptomycin (Invitrogen).  The 
vessels were then digested in 2 mg/ml collagenase A and 0.5 mg/ml elastase (Sigma-
Aldrich) in HBSS for 30 minutes, titurating the digest with a pipet every 5 minutes.  The 
remaining cell suspensions were grown in T25 tissue culture flasks in the aforementioned 
growth medium.  The cells were grown to confluence at P1 and selected for mG 
expression using a BD FACSAria cell sorter (BD Biosciences) under low-pressure 
settings.  These mG-positive cells remained in culture for 36 weeks and were frozen for 





Phalloidin staining of actin filaments in ascending and descending VSMCs from 
C57BL/6 mice 
 Ascending and descending VSMCs were cultured from C57BL/6 mice in an 
analogous fashion to SM22-mG/mT mice as above.  The cells were subsequently allowed 
to expand on a sterilized cover slip in a 6-well culture plate.  After confluence, the cells 
were fixed for 5 minutes in 3.7% formaldehyde in PBS.  The cells were then 
permeabilized with 0.1% Triton X-100 in PBS for 1 minute and incubated with a 50 
µg/ml FITC-phalloidin (Sigma-Aldrich) solution in PBS for 40 minutes at room 
temperature.  The nuclei were stained with DAPI (Vector Laboratories) and the cells 
were examined by fluorescence microscopy.  In between each step, the cells were washed 
extensively in PBS. 
 
Quantitative RT-PCR 
 To isolate total RNA, the vessel segments were disrupted by a mortar and pestle 
and rapidly resuspended in RLT lysis buffer (QIAGEN).  The tissues were homogenized 
using a QIAshredder homogenizer (QIAGEN) and the RNA was isolated using RNeasy 
mini kits (QIAGEN) according to the manufacturer’s protocol.  Total RNA was also 
isolated from cells accordingly.  Reverse transcription with random hexamer and oligo-
dT primers was performed according to the Multiscribe RT system protocol (Applied 
Biosystems).  All RT-PCR reactions were prepared with TaqMan 2× PCR Master Mix 
and pre-developed assay reagents from Applied Biosystems.  Either an iCycler or iQ5 




samples and the data. All cDNA samples were run in duplicates and RNA samples 
processed without the reverse transcriptase enzyme were used as negative controls for all 
genes assayed.  The expression level of each target was normalized to that of Gapdh. 
 
Statistical analyses 
 Student's t test and one-way analysis of variance (ANOVA) were performed using 
the GraphPad Prism 4 software program (GraphPad Software).  Differences with P < 





Differences in atherosclerotic and aneurysmal disease within the murine aorta 
 We studied the distribution of atherosclerotic lesions in apolipoprotein E-deficient 
(apoE–/–) mice in which severe hyperlipidemia leads to fat and leukocyte accumulation 
within the vessel wall.  Compared to a control C56BL/6 mice on a regular diet where the 
aorta was translucent and free of any atherosclerotic lesions, the apoE–/– mice had 
significant atherosclerosis in the ascending aorta and aortic arch (Fig. 1A).  To quantify 
the atherosclerosis development in the different parts of the aorta, the aortae from apoE–/– 
mice on a regular diet were harvested ex vivo and stained with oil red O solution (n = 9, 
Fig. 1B).  The aortic arch contained significantly more atherosclerotic lesions, followed 
by the ascending aorta, with the fewest lesions in the descending thoracic and abdominal 
aortae. 
 As with atherosclerotic disease, aneurysmal disease in the murine aorta also 
exhibits preferential development.  In order to study this, we used a murine model of 
Marfan syndrome with mice that have a heterozygous C1039G mutation in exon 25 of the 
fibrillin-1 gene, fbn1C1039G/+, analogous to the C1039Y mutation that causes classic 
Marfan syndrome in humans (39).  Comparing the aortic root and the ascending aorta of 
fbn1C1039G/+ mice to control C56BL/6 mice, we can appreciate that both of these are 
dilated grossly in fbn1C1039G/+ mice while the descending thoracic aortae appear 
comparable to that of wild-type controls (Fig. 1C).  This is confirmed when we assessed 
the vessel area quantitatively in which the aortic root and ascending aorta, but not the 





Unchanged disease predilection of thoracic aorta transplanted to abdominal aorta 
Having established that there were differences in disease development within the 
murine aorta, we investigated the role of regional hemodynamic factors and paracrine 
signals on differential disease predilection of the murine aorta by a mouse transplant 
model.  Ascending and descending aortic segments from apoE–/– mice were transplanted 
into the infrarenal abdominal aortae of syngeneic apoE–/– mice.  The mice were 
subsequently fed a “Western” diet and the aortae including the grafts were harvested after 
24 weeks.  As seen with apoE–/– mice on a regular diet, the differential predilection for 
atherosclerosis to develop in the ascending aorta and aortic arch is preserved though we 
clearly see the accelerated atherogenic effects of a “Western” diet in these mice (Fig. 2A) 
(40, 41).  Remarkably, the transplanted aortic grafts maintained their native level of 
atherosclerosis development rather than that of the abdominal aorta, which is minimal 
(Fig. 2B).  Quantifying the degree of atherosclerosis in the ascending and the descending 
aortic grafts, there was significantly more atherosclerosis in the ascending aortic graft as 
compared to the descending aortic graft (39.6 ± 3.2% vs. 20.0 ± 5.4%, n = 4, P < 0.05) 
(Fig. 2C), suggesting that the atherosclerosis development in our apoE–/– mouse 
transplant model was independent of hemodynamic conditions or local context. 
 
Cytokine responses in ascending vs. descending thoracic aorta 
 A possible reason for intrinsic disease susceptibility of different aortic segments is 
regional variation to inflammatory signals.  To study the responses to IFN-γ and TGF-β 
signaling, key cytokines in the pathogenesis of atherosclerosis and aneurysms, 




C57BL/6 mice and either treated them with IFN-γ, TGF-β, or vehicle control.  The aortic 
segments remained in culture for 6 hours and mRNA expression was analyzed (n = 4).  
The genes that we studied were chosen based on results from analogous microarray 
experiments performed on human aortic tissue (data not shown).  We see that IFN-γ 
robustly induced the expression of Cxcl10, Ddx58, Ido, and Socs1 in both the ascending 
and descending thoracic aortic segments, with a trend to greater induction of expression 
in the ascending aortic segments that reached statistical significance for Socs1 expression 
(Fig. 3A).  Compared to IFN-γ, TGF-β induction of mRNA expression was more 
selective and resulted in the upregulation of Serpine1, Ctgf, Il6, and Ccl20 in only the 
ascending aortic segments (Fig. 3B).  These results confirmed molecular differences 
between the ascending and descending aorta. 
 
Hox code of the vasculature 
Since Hox genes encode for positional identity along an AP direction, we 
investigated if they may represent stable molecular differences between aortic segments.  
We characterized the expression levels of the different Hox paralogues in the murine 
arterial vasculature by harvesting left common carotid arteries, ascending aortae, 
descending thoracic aortae, infrarenal abdominal aortae, and common femoral arteries 
from C57BL/6 mice and studied their “A” cluster expression (n = 4).  In the left common 
carotid artery, we see that there was expression of Hoxa1 through Hoxa5, with Hoxa3 
being the highest Hox cluster “A” paralogue being expressed (Fig. 4A).  The expression 
profile in the ascending aorta was quite similar to the left common carotid artery, with 




we progressed distally to the descending thoracic aorta, we see that there was a shift of 
the expression profile towards Hoxa5 through Hoxa7, with Hoxa7 having the highest 
expression, though there is still some expression of Hoxa1 through Hoxa4 (Fig. 4C).  In 
the infrarenal abdominal aorta, there was a further shift of the Hox expression profile, 
with more robust expression of Hoxa9 and Hoxa10 (Fig. 4D).  Finally, the Hox 
expression profile in the common femoral arteries was similar to the abdominal aorta, 
with Hoxa10 having the highest expression (Fig. 4E). 
 The most dramatic shift in the pattern of Hox expression was associated with the 
progression from the ascending to the descending thoracic aorta.  In order to examine this 
finding more closely, we specifically examined the expression of all Hox genes from the 
paralogues 5 through 8, designating these as the thoracic Hox paralogues, in the 
ascending, descending thoracic, and abdominal aortae (n = 4).  One can readily appreciate 
that in the ascending aorta, there was a near absence of all of these thoracic paralogues 
studied while in the descending thoracic and abdominal aortae, there was much higher 
levels of the Hox paralogues 5 through 8 (Fig. 5A, 5B, 5C).  In order to assess where this 
sharp transition occurs in the thoracic aorta, we harvested 2-mm aortic segments 
immediately proximal and distal to the aortic isthmus and we discarded the aortic isthmus 
that is less than 0.5 mm in size and extends from the left subclavian artery to the origin of 
the ligamentum arteriosum.  We studied the Hox paralogues 5 through 7 in these aortic 
segments.  With the exception of Hoxa5, all of the paralogue studied demonstrate at least 
a 2-fold difference when comparing proximal to the aortic isthmus versus distal to the 




occurs in the Hox expression pattern from the ascending to the descending aorta occurs at 
the level of the aortic isthmus. 
 
Additional molecular differences between the ascending and descending thoracic aorta 
 Since Hox genes are known as master transcriptional regulators, we were 
interested in defining additional molecules with differential expression in the ascending 
vs. descending thoracic aorta that may represent potential downstream targets of the Hox 
genes.  We investigated the expression of particular molecules based on our findings 
from microarray experiments performed on human ascending and descending thoracic 
aorta (data not shown).  The most specific molecular signature of the ascending aorta we 
identified was Tcfap2a, or transcription factor activating protein (AP)-2α (Fig. 6A, P < 
0.001).  Though not achieving statistical significance, desmocollin (Dsc) 3 appeared to 
trend towards higher expression in the ascending aorta also (Fig. 6B).  Both Msx1 and 
Isl1 expression was also found to be higher in the ascending aorta compared to the 
descending aorta (Fig. 6C, 6D, P < 0.05).  Although neither achieved statistical 
significance in our limited sample sizes, Foxd1 and Skap2 both appeared to trend towards 
higher expression in the descending thoracic aorta (Fig. 6E, 6F) similar to our results in 
human specimens.  These data document expression differences within the thoracic aorta 
of additional molecules besides Hox genes. 
 
Expression of thoracic aortic segmental markers is context-independent 
 We next investigated whether the epigenetic differences between the ascending 




this question.  Ascending and descending aortic segments from C57BL/6 mice were 
transplanted into the infrarenal abdominal aortae of C57BL/6 mice.  The transplanted 
arterial grafts were harvested after 24 weeks along with the recipient ascending aorta, 
descending thoracic aorta, and abdominal aorta immediately distal to the graft.  The 
aortic segments were analyzed for expression of selective molecular markers of 
ascending, descending thoracic, and abdominal aortae (n = 5–6).  For the ascending aortic 
grafts, we see that the graft only expresses Tcfap2a and Hoxa3, with minimal levels of 
Hoxb7, Hoxb8, Hoxd8, and Hoxa10, which closely mimicked the expression profile of 
the recipient ascending aorta (Fig. 7A).  For the descending thoracic aortic grafts, there 
was high expression of Hoxa3, Hoxb7, and Hoxb8 with minimal levels of Tcfap2a, 
Hoxd8, and Hoxa10, again closely matching the expression profile of the recipient 
descending aorta (Fig. 7B).  Finally, despite the immediate proximity of the transplanted 
grafts to the recipient abdominal aorta, neither of the transplanted grafts expressed the 
abdominal aortic segmental markers Hoxd8 and Hoxa10.  These findings show that 
despite being transplanted to a new body cavity from the thorax to the peritoneum with a 
different hemodynamic profile, the aortic segmental markers we studied remained stable, 
suggesting that the epigenetic changes present in the aorta were context-independent. 
 
Stable expression differences in cultured VSMCs 
 To determine whether these epigenetic differences between aortic segments were 
persistent under identical cell culture conditions, we first generated pure smooth muscle 
cell populations using a genetic marker.  We used SM22-mG/mT mice which specifically 




the intima and adventitia (Fig. 8A).  Ascending and descending thoracic aortae were then 
harvested from these mice, digested into a cell suspension, and grown in cell culture.  The 
cells that were propagated had the morphological appearance of smooth muscle cells 
(Fig. 8B).  However, only 50% of the cultured cells were confirmed as smooth muscle 
cells by mG expression and these cells were purified using FACS sorting (Fig. 8C).  The 
mG+ ascending and descending thoracic aortic VSMCs were subsequently kept in culture 
for 36 weeks and then analyzed for the expression of the aortic segmental markers 
Hoxa2, Tcfap2a, Hoxb7, and Hoxb8 (n = 2).  Even though these cells were passaged 
multiple times and remained in culture for a prolonged period of time, the ascending and 
descending thoracic VSMCs still maintained epigenetic changes that are characteristic of 
the original aortic segment, that is, the ascending VSMCs had high expression of Hoxa2 
and Tcfap2a with low expression of Hoxb7 and Hoxb8 while the opposite was true in the 
descending thoracic VSMCs (Fig. 8D).  These results confirmed that the Hox genes, 
which encode for positional identity within the vasculature, have a stable expression 





 We have quantified the differential atherosclerotic and aneurysmal disease 
development in the murine aorta in apoE–/– and fbn1C1039G/+ mice, respectively, which are 
commonly cited models of human vascular disease in the literature.  We also established 
that atherosclerosis development in apoE–/– mice was not dependent on hemodynamic 
conditions or local context and identified differential responses along the IFN-γ and TGF-
β cytokine axes that may explain this phenomenon as well as the selective aneurysmal 
pathology in fbn1C1039G/+ mice.  A Hox code of the murine arterial vasculature was 
described and its stable segmental expression and that of additional molecules not 
containing homeodomains was confirmed via transplantation models and cell culture. 
The apolipoprotein E-deficient mouse, or apoE–/–, has long been used as the gold 
standard for murine models of human atherosclerosis since its first description in 1992 
(42, 43).  Though the differential distribution of the atherosclerotic lesions in different 
vascular beds has been a well-recognized phenomenon, there has been no published 
report addressing this heterogeneity in the aorta to date.  Here, we show that the aortic 
arch and ascending aorta is the most heavily affected by atherosclerosis while the 
abdominal aorta remains relatively free of atherosclerotic disease.  This is in sharp 
contrast to human atherosclerosis distribution where the abdominal aorta contains the 
most atherosclerosis while the ascending aorta and the aortic arch are relatively free of 
atheromas (1-6).  Differences were also present when comparing the pattern of human 
aneurysmal disease to murine models of aneurysm development.  While Marfan 
syndrome in humans and fbn1C1039G/+ mice share aortic root involvement of the 




appears to be the norm in fbn1C1039G/+ mice (8).  Our data is also the first description of 
quantitative differences in the diameter of different aortic segments in fbn1C1039G/+ mice. 
The predominant theory on human atherosclerosis distribution is that it is 
primarily a hemodynamic phenomenon, that is, it occurs at sites with slow or disturbed 
blood flow and low wall sheer stresses (11-13).  Though the dramatic differences 
between the atherosclerosis distribution in humans and mouse models of atherosclerosis 
has not been directly addressed in the literature, multiple studies have shown that 
reductions in heart rate beneficially affects atherogenesis, leading to speculation that the 
increased exposure of the more proximal vessels to the higher resting heart rate in mice 
may be responsible for the preferential atherosclerotic lesion formation in these 
proximally-located vessels (44-46).  Thus, hemodynamic factors have been invoked as 
the only explanation for the disparate distribution of atherosclerotic lesions in humans 
and mice.  However, we show that disease susceptibility in apoE–/– mice did not change 
when the ascending and descending thoracic aortae were transplanted to a more distal 
location, the abdominal aortae.  This suggests that intrinsic properties of the vessel wall 
that differ between aortic segments also contribute to the distribution of atherosclerosis, 
besides hemodynamic and mechanical parameters.  Similar findings have been previously 
documented in canine models of atherosclerosis (47, 48). 
 Atherosclerosis is not only merely a lipid disorder but also a chronic 
inflammatory disease.  Inflammation contributes to atherogenesis through adverse effects 
on lipoprotein metabolism and arterial wall biology, via both the innate and acquired 
immune systems (49, 50).  IFN-γ is a pleiotropic cytokine expressed at high levels in 




that is a key pro-inflammatory mediator in atherogenesis (51).  IFN-γ has been implicated 
in the atherosclerotic process through its direct effects and indirectly via interleukin (IL)-
12 and IL-18 (52-56).  IFN-γ also plays a detrimental role in post-transplant graft 
arteriosclerosis as well as abdominal aortic aneurysms, further highlighting its 
importance in cardiovascular disease (57-61). 
 Though IFN-γ has been implicated in abdominal aortic aneurysms, the aortic root 
aneurysms that develop in Marfan syndrome has been clearly linked to enhanced TGF-β 
signaling (62-64).  FBN1, the gene where the primary defect in Marfan syndrome lies, is 
a principal component of the 10- to 12-nm microfibrils that form the scaffold for elastin 
assembly within the extracellular matrix.  Mutations in FBN1 within the aorta result in 
weakened and disordered elastic fibers, as well as disruption of the microfibril network 
connecting the elastic lamellae to the adjacent interstitial cells (65, 66).  In addition to 
directing elastogenesis and providing structural integrity to the elastic lamellae, fibrillin-
rich microfibrils have also been shown to sequester TGF-β within the extracellular 
matrix.  Hence, FBN1 mutations also cause impaired sequestration of latent TGF-β 
complexes, thereby making more available for activation, leading to excessive TGF-β 
signaling.  It should be noted that abnormal TGF-β signaling is also implicated in 
atherosclerosis, primary pulmonary hypertension, hereditary hemorrhagic telangiectasia, 
Marfan syndrome type 2, familial thoracic aortic aneurysms and dissections, Loeys-Dietz 
syndrome, and Ehlers-Danlos syndrome type IV (67). 
 The critical roles played by IFN-γ and TGF-β in atherosclerotic and aortic 
aneurysmal disease has been well-elucidated as described above.  What is not evident is 




certain parts of the aorta, i.e. atherosclerosis in the ascending aorta and aortic arch, and 
aneurysmal dilatation of the aortic root and ascending aorta in the murine models 
described above.  We propose that there is a differential response to the IFN-γ and TGF-β 
signaling axis in the ascending and descending thoracic aorta, thus accounting for the 
preferential disease phenotype in the aforementioned aortic diseases. 
IFN-γ-induction of Cxcl10, also known as IFN-γ-inducible protein of 10 kDa (IP-
10), expression from the C-X-C chemokine receptor 3 (CXCR3) axis was not surprising 
given that the CXCR3 ligands are strongly induced by IFN-γ, particularly in vascular 
cells (68).  CXCR3 is preferentially expressed by Th1 cells, further highlighting their role 
in atherogenesis (69).  Ddx58, or retinoic-acid-inducible gene I (RIG-I), is a cytoplasmic 
RNA helicase that recognizes RNA species produced in the cytoplasm (70).  Though 
RIG-I is classically thought to be involved in the recognition of viral nucleic acids, RIG-I 
is also highly expressed in intimal macrophages in atherosclerotic lesions, suggesting 
possible involvement of RIG-I in atherosclerosis (71).  Ido is an IFN-γ-inducible, 
intracellular enzyme that catalyzes the first and rate-limiting step in oxidative catabolism 
of the essential amino acid tryptophan along the kynurenine pathway (72).  Ido 
suppresses T-cell responses and promotes immune privilege of the media from leukocytic 
infiltration in atherosclerosis and graft arteriosclerosis, though these findings may not 
necessarily apply to murine systems due to species differences in vascular cell 
interactions with T cells (73).  Suppressors of cytokine signaling (Socs) proteins are 
intracellular regulators of receptor signal transduction, mainly Janus kinase/signal 
transducers and activators of transcription (74).  High expression of Socs1 has been found 




aortic plaques in apoE–/– mice, highlighting their role as key regulators of vascular cell 
responses (75).  Most intriguing is that for these four molecules, Cxcl10, Ddx58, Ido, and 
Socs1, that have been implicated as key regulators in atherogenesis, the ascending aortic 
segments showed a higher degree of induction of expression by IFN-γ compared to the 
descending thoracic aortic segments, concurrent with our observation that atherosclerosis 
in the murine aorta occurs in the ascending rather than the descending thoracic aorta. 
Serpine1, or plasminogen activator inhibitor type 1 (PAI-1), and connective tissue 
growth factor (Ctgf) are both molecules that are directly involved in TGF-β signaling.  
PAI-1 is a direct downstream target of the TGF-β type 1 receptor ALK5, which signals 
via Smad2 and Smad3, and generally inhibits cell proliferation and migration but favors 
vessel maturation.  Ctgf is a downstream mediator that is able to block the negative 
feedback loop provided by Smad7, thus allowing constitutive activation of the TGF-β 
signaling pathway (76).  Il6 and Ccl20 are both inflammatory molecules that can be 
induced by IL-17 in several human cell types in vitro (77).  Of note, Ccl20 is the only 
known ligand of CCR6, which is generally expressed only by IL-17–producing T cells, 
although not completely specific (78, 79).  Furthermore, the combination of TGF-β and 
Il6 is sufficient to induce Th17 differentiation in mouse naive T cells, possibly suggesting 
that the selective aortic aneurysm development in fbn1C1039G/+ mice may be due to 
exaggerated TGF-β responses in the ascending aorta leading to Th17 differentiation (80-
84). 
We have correlated stable molecular differences between the aortic segments with 
differing cytokine responses.  Although there have been papers published in the literature 




vasculature, there have been no published reports of the differential expression of the 
Hox paralogues in the arterial vasculature (30, 85-87).  To address this issue, we 
described a Hox code of the murine arterial vasculature.  The “A” cluster was chosen 
over the other Hox clusters because the “A” cluster has the greatest number of different 
paralogous groups preserved, with the absence of only paralogues 8 and 12 (22).  As 
expected, there was a cephalad to caudal progression of the Hox paralogues in the arterial 
vasculature.  This closely mimics that of the well-characterized Hox patterning in the 
axial skeleton, female reproductive system, and gastrointestinal tract, suggesting that the 
spatial-temporal relationship of the Hox paralogues is maintained in the arterial 
vasculature (22, 88, 89). 
 Based on our findings of the near absence of Hox paralogues 5 though 8 in the 
ascending aorta and its dramatic upregulation in the descending thoracic aorta, we 
suspected that there might be a “transition zone” where the Hox expression profile shifts 
from an ascending to a descending thoracic aorta-type pattern.  A logical candidate for 
this “transition zone” based on the ontogeny of VSMCs in the aorta is the aortic isthmus.  
Neural crest cells give rise to VSMCs in the cephalic and cardiac outflow region, 
extending to the ligamentum arteriosum (90, 91).  The developmental origin of the 
descending aorta distal to the ligamentum arteriosum is less clear.  Traditionally, it was 
assumed that splanchnic lateral plate mesoderm was the primary contributor to the 
development of descending aorta (92-95).  However, more recent studies have challenged 
this paradigm, suggesting that paraxial mesoderm contribute to VSMCs in the descending 
aorta and perhaps may be entirely somite-derived (87, 96, 97).  Regardless, it is clear that 




arteriosum.  As expected, we saw a substantial difference in the expression of Hox 
paralogues 5 though 7 across the aortic isthmus, likely due to the differing embryological 
origins of the aorta proximal and distal to this region. 
 In attempt to gain mechanistic insight into how smooth muscle heterogeneity 
occurs on a molecular level, we identified further molecular differences between the 
ascending and descending thoracic aorta.  Tcfap2a, Dsc3, Msx1, and Isl1 were transcripts 
we identified that were expressed at higher levels in the ascending aorta compared to the 
descending thoracic aorta.  AP-2 transcription factors are localized predominantly in the 
nucleus, where they bind to target sequences and regulate transcription of target genes 
and modulate signal transduction pathways such as the Wnt developmental signaling 
pathway (98).  Tcfap2a is expressed in neural crest cells, the peripheral nervous system, 
facial and limb mesenchyme, and various epithelia of the developing embryo and the 
extraembryonic trophectoderm with mutations leading to disturbances of facial and limb 
development (99-101).  Dsc3 is part of the extracellular domain of desmosomes, which 
are adhesive intercellular junctions of epithelia and cardiac muscle.  Both Msx1 and Isl1 
contain the homeodomain and belong to the homeobox gene superfamily, though of 
different classes.  Hox genes and Msx1 both belong to the ANTP class whereas Isl1 
belongs to the LIM class of homeobox genes (102).  Msx1 is expressed during 
embryogenesis at many sites of epithelial-mesenchymal inductive interactions, such as 
limb and tooth buds, heart, branchial arches and craniofacial processes, but also in the 
roof plate and adjacent cells in the dorsal neural tube and neural crests (103).  
Interestingly, it is known that Msx genes are immediate effectors of bone morphogenetic 




superfamily, which would be consistent with our findings suggesting exaggerated TGF-β 
responses in the ascending aorta (104, 105).  Isl1 is implicated in the generation of 
pancreatic endocrine islet cells and motor neurons (106, 107). 
 Foxd1 and Skap2 were transcripts we identified that were expressed at higher 
levels in the descending thoracic aorta compared to the ascending aorta.  Interestingly, 
both Foxd1 and Skap2 are involved in T cell activation.  Foxd1 is part of the forkhead 
family of transcription factors that play critical roles in immune homeostasis (108, 109).  
Foxd1 appears to regulate inflammatory Th reactions by its direct effects on NF-AT and 
indirectly via Foxj1 antagonizing NF-κB, both key inflammatory transcription factors 
(110).  Ligation of CD4/CD8-p56lck and the T cell receptor complexes results in 
increased phosphorylation of FYB, which is implicated in the negative regulation of IL-2 
transcription, a key cytokine in the development of adaptive immune responses (111, 
112).  Skap2 is part of an interactive matrix for FYB along with Skap1 (113).  Taken 
together, these findings may help explain why the descending thoracic aorta is relatively 
free of atherosclerotic disease compared to the ascending aorta in mice due to higher 
expression of these immunoregulatory molecules. 
 If the epigenetic differences within the murine aorta account for the heterogeneity 
of the aforementioned vascular diseases, their stable expression pattern should be 
associated with persistent disease predilection irrespective of local hemodynamic 
conditions or paracrine signals from surrounding tissues.  Transplant experiments pointed 
to both stable epigenetic differences and disease susceptibility, though documenting this 
in cell culture proved to be more challenging.  Protocols to isolate VSMCs from murine 




before enzymatic dissociation of the aortic tissue into a cell suspension or outgrowth 
from explants (114-116).  While conventional growth media used for culturing VSMCs 
does not support the growth of ECs from residual intimal tissue, fibroblasts from residual 
adventitial tissue are able to proliferate under these conditions.  Complicating this matter 
is that there are no specific cell surface markers that reliably distinguish fibroblasts from 
VSMCs.  To overcome this, we generated SM22-mG/mT mice that express mG in the 
media while expressing mT in the intima and adventitia, thus allowing both positive and 
negative selection by FACS cell sorting.  Note that only approximately 50% of the cells 
isolated from SM22-mG/mT aortae were mG+, suggesting significant fibroblast 
contamination of the cell colonies, though this could partially be explained with 
incomplete Cre-mediated DNA recombination (117).  Using this method, we were able to 
confirm stable expression differences in a pure population of VSMCs. 
 There have been multiple reports published in the literature supporting the 
interaction of homeoproteins with the TGF-β signaling axis (118-122).  The evidence 
ranges from collaboration with Smad proteins for downstream repression of target genes 
affected by the TGF-β to direct binding to the MH2 domain of Smad5.  Though there are 
no published reports that link homeoproteins to IFN-γ signaling to date, there is an 
emerging paradigm that at the molecular level, Hox proteins are not “master” regulatory 
proteins that dictate how target genes behave.  Rather, they may exert their great 
influence by virtue of their simple binding specificity, broad domains of expression, and 
versatile collaborative properties, thus leaving the possibility that homeoproteins do 
indeed interact with IFN-γ signaling molecules under the appropriate circumstances 




differences in TGF-β and IFN-γ signaling in the ascending and descending thoracic aorta 
and will include transfection of cultured VSMCs with various different Hox plasmids for 
Hox overexpression, knockdown of Hox genes by siRNA, and generation of Hox 
knockout mice. 
 In conclusion, the topographical distribution of vascular diseases causing 
significant morbidity and mortality worldwide such as atherosclerosis and aneurysmal 
disease may not be a simple phenomenon due to mechanical or local contextual factors 
acting on the vessel wall.  We provide evidence that point to inherent phenotypic 
differences in the arterial vasculature, in the form of differential cytokine responses, and 
molecular differences, in the form of a Hox “code.”  We also developed transgenic mice 
that allows for further in vitro experiments utilizing pure populations of murine aortic 
VSMCs.  It is our hope that by better understanding phenotypic differences that are 
present in the arterial vasculature, we can better understand the pathogenic mechanisms 




FIGURE REFERENCES AND LEGENDS 
 
 
Figure 1.  Histologic and morphometric evidence of differences in atherosclerotic and 
aneurysmal disease within the murine aorta.  (A) Gross appearance of the thoracic aorta 
of wildtype (WT) C57BL/6 mice versus apoE–/– mice on a “Western” diet for 16 weeks.  
The ascending aorta (Asc), aortic arch (Arch), and descending thoracic aorta (Desc) are 
labeled in the WT aorta as well as their boundaries of brachiocephalic artery (BA), left 
subclavian artery (LSA), and ligamentum arteriosum (LA), respectively.  The arrows 
indicate atherosclerotic plaques in the apoE–/– aorta.  (B) Quantitative analysis of 
atherogenesis in apoE–/– mice on a regular diet using oil red O+ area divided by the area 
of discrete aortic segments including the abdominal aorta (Abd) (n = 9).  (C) EVG–
stained 5-µm transverse sections of aortic root, ascending, and descending thoracic aorta 
from WT and fbn1C1039G/+ mice.  Bars represent 4 mm for all aortic segments.  (D) 
Quantitative analysis of the vessel areas in WT and fbn1C1039G/+ mice (n = 4–8).  Means ± 






Figure 2.  Unchanged atherosclerosis predilection of thoracic aorta transplanted to 
abdominal aorta.  (A) Oil red O staining of the aorta ex vivo from ascending to abdominal 
and descending to abdominal aortic transplants in apoE–/– mice on a “Western” diet for 
24 weeks.  (B) Higher magnification views of the oil red O staining of the ascending to 
abdominal and descending to abdominal aortic grafts.  (C) Degree of atherosclerosis in 
the transplanted grafts quantified by oil red O+ area (n = 4).  Means ± SEM are shown, * 




Figure 3.  Differential responses to IFN-γ and TGF-β in the ascending vs. descending 
thoracic aorta.  Equal length segments of ascending and descending thoracic aortic 
segments from C57BL/6 mice in organ culture were treated with rmIFN-γ (10 ng/ml), 
rhTGF-β1 (10 ng/ml), or left untreated for 6 hours.  RT-PCR results are grouped by 
molecules where expression was primarily (A) induced by IFN-γ or (B) induced by TGF-
β (n = 4).  Means ± SEM are shown, * P < 0.05 for treated vs. untreated, # P < 0.05 for 




Figure 4.  Hoxa “code” of the murine arterial vasculature.  Equal length segments of various arteries were harvested from C57BL/6 
mice and analyzed for their Hox “A” cluster expression.  RT-PCR results are shown from the (A) left common carotid arteries, (B) 






Figure 5.  Transition of the Hox code at the aortic isthmus.  Equal length segments of (A) ascending, (B) descending thoracic, and (C) 
abdominal aortic segments from C57BL/6 mice were harvested and analyzed for their expression of Hox paralogues 5 through 8 (n = 
4).  Additionally, 2-mm segments of the aorta immediately (D) proximal and (E) distal to the aortic isthmus were also harvested while 






Figure 6.  Non-Hox molecular differences between the ascending and descending 
thoracic aorta.  Equal length segments of ascending and descending thoracic aortic 
segments from C57BL/6 mice were harvested and analyzed for their expression of (A) 
Tcfap2a, (B) Dsc3, (C) Msx1, (D) Isl1, (E) Foxd1, and (F) Skap2 (n = 4–12).  Means ± 
SEM are shown, * P < 0.05, ** P < 0.001 (unpaired Student’s t test). 
  
 
Figure 7.  Unchanged expression of segmental markers in thoracic aorta transplanted to abdominal aorta.  (A) RT-PCR analysis of the 
transplanted ascending aortic graft, recipient ascending, descending thoracic, and abdominal aorta in ascending to abdominal aortic 
transplanted C57BL/6 mice for Tcfap2a, Hoxa3, Hoxb7, Hoxb8, and Hoxa10 24 weeks after transplantation (n = 5–6).  (B) Analogous 







Figure 8.  Stable expression differences in VSMCs cultured from SM22-mG/mT mice.  
(A) Fluorescence microscopy of aorta from SM22-mG/mT mice with mG signal (green) 
in the media, mT signal (red) in the intima and adventitia, and DAPI signal (blue) of the 
nuclei.  The bar represents 100 µm.  (B) FITC-phalloidin (green) and DAPI (blue) 
staining of actin filaments and nuclei, respectively, in ascending and descending thoracic 
VSMCs cultured from C57BL/6 mice.  The bars represent 25 µm.  (C) FACS sort of 
ascending and descending thoracic VSMCs cultured from SM22-mG/mT mice.  43.5% of 
the ascending VSMCs exhibitied mG positivity while 56.5% of the descending thoracic 
VSMCs did so.  (D) RT-PCR analysis of Hoxa2, Tcfap2a, Hoxb7, and Hoxb8 expression 
in mG+ ascending and descending thoracic VSMCs after 36 weeks in culture (n = 2).  
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